Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligometastatic Prostate Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06205316
What this trial is testing

SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

Who this might be right for
Biochemically Recurrent Prostate CarcinomaOligometastatic Prostate CarcinomaRecurrent Prostate Adenocarcinoma+4 more
Mayo Clinic 118
Testing effectiveness (Phase 2)Active Not RecruitingNCT03569241
What this trial is testing

PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases

Who this might be right for
Prostate CancerProstate Cancer MetastaticMetastatic Cancer+1 more
University Hospital, Ghent 196
Early research (Phase 1)Active Not RecruitingNCT05079698
What this trial is testing

Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 29
Not applicableLooking for participantsNCT04983095
What this trial is testing

Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticRadiation TherapyPositron-Emission Tomography
Karin Soderkvist 118
Not applicableNot Yet RecruitingNCT05707468
What this trial is testing

Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer

Who this might be right for
Oligometastatic Prostate Carcinoma
Changhai Hospital 200
Not applicableWithdrawnNCT05245435
What this trial is testing

Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of Vienna
Not applicableUnknownNCT04997252
What this trial is testing

An Evaluation of the Efficacy and Safety of Apalutamide as Neoadjuvant Endocrine Therapy in High-Risk and Oligometastatic Prostate Cancer

Who this might be right for
High-Risk and Oligometastatic Prostate Cancer
Zhujiang Hospital 50
Not applicableActive Not RecruitingNCT07766486
What this trial is testing

Prospective Study on the Role of Radical Prostatectomy in Oligo-metastatic Hormone-sensitive Prostate Cancer in Patients on Androgen Deprivation Therapy

Who this might be right for
Oligometastatic Hormone-Sensitive Prostate CancerProstate Adenocarcinoma
Fondazione del Piemonte per l'Oncologia 30
Testing effectiveness (Phase 2)Study completedNCT04992026
What this trial is testing

The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer

Who this might be right for
ProstatectomyOligometastatic Prostate CancerAbiraterone
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 130
Early research (Phase 1)Looking for participantsNCT07824349
What this trial is testing

JUR-003 in Adult Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate CancerOligometastatic Prostate Cancer (OMPC)Metastatic Hormone Sensitive Prostate Cancer
Juri Biosciences, Inc. 210
Testing effectiveness (Phase 2)Looking for participantsNCT05223803
What this trial is testing

TERPS Trial for de Novo Oligometastic Prostate Cancer

Who this might be right for
Prostate CancerOligometastatic Disease
University of Maryland, Baltimore 122
Testing effectiveness (Phase 2)Active Not RecruitingNCT03902951
What this trial is testing

Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate AdenocarcinomaProstate Adenocarcinoma With Focal Neuroendocrine DifferentiationRecurrent Prostate Carcinoma+1 more
Jonsson Comprehensive Cancer Center 28
Testing effectiveness (Phase 2)UnknownNCT02742675
What this trial is testing

Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)

Who this might be right for
Prostate Cancer
Fudan University 200
Not applicableLooking for participantsNCT06978296
What this trial is testing

HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS)

Who this might be right for
Prostate Cancer Metastatic DiseaseOligometastatic Prostate Cancer (OMPC)
Institut Cancerologie de l'Ouest 18
Testing effectiveness (Phase 2)UnknownNCT04641078
What this trial is testing

Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer RecurrentProstate Cancer Metastatic+2 more
University Hospital, Ghent 124
Testing effectiveness (Phase 2)Study completedNCT03556904
What this trial is testing

FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 14
Not applicableLooking for participantsNCT06674863
What this trial is testing

Addressing Health Literacy With a Tailored Survivorship Care Plan

Who this might be right for
Localized Prostate CarcinomaOligometastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
Emory University 150
Not applicableLooking for participantsNCT05209243
What this trial is testing

START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPC

Who this might be right for
Prostate CancerStereotactic Body Radiation Therapy
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic 266
Testing effectiveness (Phase 2)Active Not RecruitingNCT05053152
What this trial is testing

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

Who this might be right for
Oligometastatic Prostate CarcinomaProstate AdenocarcinomaProstate Ductal Adenocarcinoma+2 more
NRG Oncology 194
Testing effectiveness (Phase 2)Active Not RecruitingNCT04655365
What this trial is testing

Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 50
Next Page